1. Home
  2. WPC vs MDGL Comparison

WPC vs MDGL Comparison

Compare WPC & MDGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo W. P. Carey Inc. REIT

WPC

W. P. Carey Inc. REIT

HOLD

Current Price

$72.84

Market Cap

14.6B

Sector

Real Estate

ML Signal

HOLD

Logo Madrigal Pharmaceuticals Inc.

MDGL

Madrigal Pharmaceuticals Inc.

HOLD

Current Price

$435.31

Market Cap

10.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WPC
MDGL
Founded
1973
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.6B
10.0B
IPO Year
1998
2005

Fundamental Metrics

Financial Performance
Metric
WPC
MDGL
Price
$72.84
$435.31
Analyst Decision
Hold
Strong Buy
Analyst Count
8
14
Target Price
$70.88
$637.92
AVG Volume (30 Days)
1.4M
351.7K
Earning Date
05-12-2026
05-19-2026
Dividend Yield
4.99%
N/A
EPS Growth
N/A
41.32
EPS
1.33
N/A
Revenue
$1,716,485,000.00
$180,133,000.00
Revenue This Year
$4.65
$58.70
Revenue Next Year
$5.88
$46.88
P/E Ratio
$55.64
N/A
Revenue Growth
8.43
N/A
52 Week Low
$54.24
$265.00
52 Week High
$75.69
$615.00

Technical Indicators

Market Signals
Indicator
WPC
MDGL
Relative Strength Index (RSI) 54.73 39.39
Support Level $66.79 $410.78
Resistance Level $74.72 $452.22
Average True Range (ATR) 1.23 19.93
MACD -0.12 -0.33
Stochastic Oscillator 42.83 25.47

Price Performance

Historical Comparison
WPC
MDGL

About WPC W. P. Carey Inc. REIT

W.P. Carey Inc is a real estate investment trust principally involved in the ownership of properties located in the U.S., Western Europe, and Northern Europe. W.P. Carey organizes its operations into Real Estate and Investment Management segments. The vast majority of the company's income is derived from its Real Estate division in the form of lease revenue from long-term agreements with companies. W.P. Carey's real estate portfolio is primarily comprised of single-tenant office, industrial, warehouse, and retail facilities located around the world. majority of the company's revenue comes from properties in the USA. Its Investment Management unit generates revenue from providing real estate advisory and portfolio management services to other REITs.

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.

Share on Social Networks: